Business
Nine of the largest pharma companies ink deals with Trump to lower drug prices
U.S. President Donald Trump speaks during an event in the Roosevelt Room of the White House December 19, 2025 in Washington, DC. Trump delivered remarks on lowering prescription drug prices during the event.
Alex Wong | Getty Images
Several of the largest U.S. and European-based drugmakers inked deals with President Donald Trump on Friday to voluntarily sell their medications for less, as his administration pushes to link the nation’s drug prices to cheaper ones abroad.
That includes Merck, Bristol Myers Squibb, Amgen, Gilead, GSK, Sanofi, Roche‘s Genentech, privately-held Boehringer Ingelheim and Novartis. In exchange, the companies agreed to a three-year grace period during which their products won’t face Trump’s planned pharmaceutical-specific tariffs — as long as the drugmakers further invest in U.S. manufacturing.
Among the most notable pledges on Friday is that Bristol Myers Squibb will offer Eliquis, its blockbuster blood thinner and top-prescribed product, for free to Medicaid.
The companies make up the majority of the 17 drugmakers Trump sent letters to in July, calling on them to lower prices as part of his “most favored nation” policy. Trump signed an executive order in May to revive that policy, calling for prices to be increased outside of the U.S. and to “end global freeloading.”
“As of today, 14 out of the 17 largest pharmaceutical companies … have now agreed to drastically lower drug prices for … the American people and the American patients,” Trump said at an event on Friday. “This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit.”
Johnson & Johnson, AbbVie and Regeneron are the remaining companies among the largest that haven’t signed drug pricing deals. But Trump noted that Johnson & Johnson “will be here next week.”
How the drug pricing deals will work
The full terms of the deals were not immediately released, which makes it unclear how broad their impact will be.
The nine drugmakers agreed to take measures to reduce U.S. drug prices, including selling their existing treatments to Medicaid patients at the lowest “most favored nation” prices, and guaranteeing that pricing for new medicines. Trump said the drugmakers also agreed to list their most popular drugs on his upcoming direct-to-consumer website, TrumpRx, which is launching in January.
Some companies also launched new or expanded existing direct-to-consumer offerings for certain drugs. For example, Gilead said in a release that it will launch a program that will enable patients to access its hepatitis C treatment and cure, Epclusa, at a discounted price.
Sanofi said it will offer discounts of nearly 70% on certain medicines to treat infections and cardiovascular and diabetic conditions on TrumpRx and other direct-to-consumer platforms.
Merck said it will offer three diabetes medications, Januvia, Janumet and Janumet XR, at a roughly 70% discount to cash-paying patients through a direct-to-patient program. That program will be extended to the company’s experimental daily cholesterol pill if it gets approved in the U.S., according to the company.
“I reflect on your goal of driving affordability and access to Americans, but equally, getting prices up outside the United States,” Merck CEO Robert Davis said during the press conference. “And we’re 100% supportive of your actions.”
Meanwhile, Amgen will expand its existing direct-to-patient program to include preventative migraine medication Aimovig and autoimmune treatment Amjevita, at 60% and 80% discounted monthly prices, respectively.
Earlier this year, Trump announced agreements with Eli Lilly, Novo Nordisk, Pfizer, AstraZeneca and EMD Serono to sell certain drugs directly to patients at a discount, in exchange for exemptions from his planned pharmaceutical tariffs and other benefits, such as fast-tracked reviews of new drugs.
U.S. prescription drug prices on average are nearly three times higher than overseas, according to a 2024 study by Rand Corp. Prices for branded drugs were more than four times higher, the report found.
Trump signed an executive order in May to revive the policy of most favored nation, calling for prices to be increased outside of the U.S. and to “end global freeloading.”
Trade association PhRMA, which represents many major pharma companies, has said that most-favored nation pricing isn’t the best way to lower drug costs for Americans and instead blamed pharmacy benefit managers for the price disparity.
The U.S. is the single most important market for many drugmakers, regardless of their home country. Despite being based across the Atlantic, European pharma companies are heavily exposed to the U.S. market, with half of the 10 largest companies on the Continent generating a majority of their sales in the U.S.
Business
Top stocks to buy today: Stock recommendations for February 5, 2026 – check list – The Times of India
Top stock market recommendations: According to Aakash K Hindocha, Deputy Vice President – WM Research, Nuvama Professional Clients Group, the top buy calls for today are: Petronet, MRPL, and CCL. Here’s his view on Nifty, Bank Nifty, and the top stock picks for February 5, 2026:Index View: NiftyNifty has been on a roller coaster from the start of this calendar month with India VIX seeing over 80% gain in volatility from January 01, 2026. With large gap up opening unable to sustain, the gap between last week highs and this week’s low is likely to get filled sooner this month. This gap however, should be used to create longs with support seen at the rising 200 DMA for targets of 25940 / 26100.Bank NiftyBank Nifty has already done what we are expecting Nifty to do, which is it has tested its last week’s highs in yesterday’s volatile session. Breaking of current week’s low and reversing near 59700 odd is likely to be used as an opportunity to create fresh longs on the index, as Bank Nifty has experienced 59650 as significant resistance over the past 9 weeks of trade and the same is likely to act as support based on classical technical thesis.PETRONET (BUY):
- LCP: 298
- Stop Loss: 287
- Target: 324
After its initial breakout from 15 month sloping trendline, PETRONET had been lacking triggers making it wait within a 6-8% band. With the 200 DMA now supportively reclaimed and stock closing at 6 month highs, momentum buyers could come in. Given the set up an 8-10% rally can unfold.MRPL (BUY):
- LCP: 182
- Stop Loss: 171
- Target: 201
MRPL has recovered over 30% in the last 9 trading sessions given its reversal from the 200 DMA support. A repetitive higher low formation was also seen on weekly charts of the same. Stock is on the verge of closing at 16 month highs on weekly charts if it retains at CMP until Friday’s close which also corresponds to an end to the stock’s 2 year corrective phase.CCL (BUY):
- LCP: 1002
- Stop Loss: 957
- Target: 1078
CCL had been consolidating for the past 12 weeks with a negative bias correcting over 15% from its all time highs. With lower high formations seen from the start of this calendar year and a trendline breakout of this consolidation seen this week, prices indicate a start of a fresh up move unfolding back to its previous highs.(Disclaimer: Recommendations and views on the stock market, other asset classes or personal finance management tips given by experts are their own. These opinions do not represent the views of The Times of India)
Business
Criminals using AI to clone voices and set up direct debits
Criminals are using AI to clone people’s voices and set up unauthorised direct debits over the phone, National Trading Standards (NTS) has warned.
NTS said “advanced” voice cloning was part of an organised criminal operation that appeared to be targeting older people.
Fraudsters began the process by asking victims to participate in a so-called “lifestyle survey” phone call, which was actually designed to gather personal, health and financial details.
The criminals then used this information to create AI-generated voice clones to simulate consent for direct debits.
The voice clones could then be used to set up payments with banks and other legitimate businesses and financial providers without the victim’s knowledge, NTS said.
Victims often did not realise payments were being taken, it warned.
Latest figures from NTS suggests that UK adults now receive an average of seven scam calls or texts per month, with about one in five (21%) receiving them most days and 9% receiving them every day.
NTS said it blocked almost 21 million scam phone calls and shut down 2,000 numbers in a six-month period.
Louise Baxter, head of the NTS scams team, said: “What we’re seeing is a deeply disturbing combination of old and new: traditional phone scams supported by disturbing new techniques.
“Criminals are using AI not just to deceive victims, but to trick legitimate systems into processing fraudulent payments.
“This is no longer just a nuisance – it’s a co-ordinated, sophisticated operation targeting some of the most situationally vulnerable consumers in society.
“We urge everyone to speak to friends and relatives about scam calls, check bank statements regularly and report anything suspicious.”
John Herriman, chief executive at the Chartered Trading Standards Institute (CTSI), said: “This alarming new twist in phone-based fraud shows just how quickly criminals are exploiting emerging technologies to prey on the public.
“Voice cloning takes scam calls to a sinister new level, making it even harder for legitimate businesses and consumers to distinguish real interactions from fraudulent ones.
“Trading Standards teams across the UK are working tirelessly to disrupt these operations but we need the public to stay alert, talk to loved ones about the risks and report anything suspicious.”
Which? consumer law spokeswoman Lisa Webb said: “You shouldn’t have to worry about your own voice being used against you in this way but sadly we’ve reached a stage where every phone call must be treated with suspicion. If you get any calls out of the blue, don’t be afraid to hang up, genuine callers won’t mind.
“If you see any direct debits or transactions on your bank account that you don’t recognise, contact your bank immediately using the number on the back of your card. You should also report any scams to Police Scotland or Report Fraud to investigate.
“It’s also worth making sure you’re registered with the telephone preference service to opt out of unsolicited marketing calls, that way you’ll know that any unexpected marketing or sales calls are either a rogue company or a scammer.”
Business
Scotland will be left behind unless SNP ends nuclear objection, group warns
Scotland risks being left behind in the world unless the Government urgently ends its opposition to nuclear energy, a coalition of businesses and campaign groups has warned.
Scotland for Nuclear Energy, launched by campaign groups Nuclear for Scotland and Britain Remade, said Scotland could miss out on jobs and economic growth as other countries invest in new nuclear technology.
While energy is reserved to Westminster, powers over planning has given the SNP an effective veto over nuclear energy – something the party has long opposed but which is backed by Labour and the Tories.
Scotland for Nuclear Energy claimed the country could build on its nuclear heritage to install new nuclear reactors in a move it said would complement, rather than compete with, renewable energy.
Sam Richards, chief executive officer of Britain Remade, said: “Scotland has done brilliantly with renewables, but the wind doesn’t always blow when we need it.
“Nuclear is clean, reliable baseload power that keeps the lights on, stabilises bills and attracts huge investment.
“At a time when countries across Europe are embracing nuclear as a safe, clean and reliable part of the energy mix, the Scottish Government’s refusal to even consider it is deeply irresponsible.
“They should drop their outdated opposition to nuclear power. If they don’t, it will be the people of Scotland that miss out.”
The group said while Scotland still has four registered nuclear sites, only one – Torness nuclear plant – is operation and generating power, providing what it described as “clean power” to two million homes.
It pointed to polling which shows majority support for nuclear energy.
Trudy Morris, chief executive of North Highland Chamber of Commerce, also backed the campaign.
She said: “Here in the north Highlands, we have lived the reality of nuclear energy for decades and the transformative impact of NRS Dounreay on our economy, skills base and communities is impossible to ignore.
“It has supported thousands of high-value jobs, invested in our supply chains and created expertise that continues to benefit the region.
“The chamber supports a mixed energy economy. Renewables are central to Scotland’s future but they work best alongside clean, reliable baseload power.
“With the highest safety standards, nuclear can complement renewables, strengthen energy security, cut emissions and ensure communities like ours continue to share in the economic benefits.”
The Scottish Campaign to Resist the Atomic Menace said nuclear energy was a “distraction”.
Pete Roche, spokesman for the group, said: “As renewable energy-rich Scotland heads towards an election, it is all too predictable that nuclear lobbyists are again arguing that Scotland needs new nuclear power stations.
“They misleadingly present them as cheap, clean and ‘green’ – yet this is as far from the truth as it was 70 years ago when it was promised that nuclear energy would be ‘too cheap to meter’.
“An energy system built around renewables is already happening. Meeting all our needs this way is not just possible but it’s quicker and cheaper without the costly distraction of new nuclear.
“Low-cost renewable energy combined with storage, flexible power to balance the grid and smart local energy systems will make the best use of our incredible renewable resources and engineering know-how.
“Why dilute that by backing eye-wateringly expensive nuclear power stations?”
The Scottish Government has been approached for comment.
-
Sports1 week agoPSL 11: Local players’ category renewals unveiled ahead of auction
-
Entertainment1 week agoClaire Danes reveals how she reacted to pregnancy at 44
-
Sports1 week agoCollege football’s top 100 games of the 2025 season
-
Business1 week agoBanking services disrupted as bank employees go on nationwide strike demanding five-day work week
-
Politics1 week agoTrump vows to ‘de-escalate’ after Minneapolis shootings
-
Sports1 week agoTammy Abraham joins Aston Villa 1 day after Besiktas transfer
-
Tech1 week agoBrighten Your Darkest Time (of Year) With This Smart Home Upgrade
-
Entertainment1 week agoK-Pop star Rosé to appear in special podcast before Grammy’s
